Aker BioMarine ASA's market cap is currently €639.42M. The company's EPS TTM is €-0.0688864168; its P/E ratio is 3.87; Aker BioMarine ASA is scheduled to report earnings on July 11, 2025, and the estimated EPS forecast is €0.00. See an overview of income statement, balance sheet, and cash flow financials.
